Form D — Protibea Therapeutics, Inc.
0001864104-25-000002 · filed 2025-08-18
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $11,700,000
- Total sold
- $200,000
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Protibea Therapeutics, Inc.
- CIK
- 1864104
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 1108 LEGACY CROSSING
GEORGETOWN, TX 78628 - Phone
- 915-490-0715
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
William Chamberlin · Executive OfficerGeorgetown, TX Find on LinkedIn ↗
-
Jim Moriarty · Executive OfficerGeorgetown, TX Find on LinkedIn ↗
-
Yu Ge · DirectorGeorgetown, TX Find on LinkedIn ↗
-
Harry Oken · DirectorGeorgetown, TX Find on LinkedIn ↗
View original on SEC EDGAR.